nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP2C19—epilepsy syndrome	0.188	0.654	CbGaD
Etravirine—ABCB1—epilepsy syndrome	0.0996	0.346	CbGaD
Etravirine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.022	0.0431	CbGbCtD
Etravirine—CYP2C19—Trimethadione—epilepsy syndrome	0.0205	0.04	CbGbCtD
Etravirine—CYP2C19—Felbamate—epilepsy syndrome	0.0205	0.04	CbGbCtD
Etravirine—ABCB1—Levetiracetam—epilepsy syndrome	0.0194	0.038	CbGbCtD
Etravirine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0193	0.0376	CbGbCtD
Etravirine—CYP2C9—Trimethadione—epilepsy syndrome	0.017	0.0333	CbGbCtD
Etravirine—CYP2C19—Clobazam—epilepsy syndrome	0.0167	0.0326	CbGbCtD
Etravirine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.016	0.0313	CbGbCtD
Etravirine—CYP2C19—Carbamazepine—epilepsy syndrome	0.0138	0.027	CbGbCtD
Etravirine—ABCB1—Clobazam—epilepsy syndrome	0.0135	0.0263	CbGbCtD
Etravirine—ABCB1—Lamotrigine—epilepsy syndrome	0.013	0.0253	CbGbCtD
Etravirine—CYP2C19—Primidone—epilepsy syndrome	0.0129	0.0252	CbGbCtD
Etravirine—CYP2C19—Phenytoin—epilepsy syndrome	0.0124	0.0243	CbGbCtD
Etravirine—CYP2C19—Propofol—epilepsy syndrome	0.0116	0.0226	CbGbCtD
Etravirine—CYP2C9—Carbamazepine—epilepsy syndrome	0.0115	0.0225	CbGbCtD
Etravirine—ABCB1—Carbamazepine—epilepsy syndrome	0.0112	0.0218	CbGbCtD
Etravirine—CYP2C19—Phenobarbital—epilepsy syndrome	0.0111	0.0216	CbGbCtD
Etravirine—CYP2C9—Primidone—epilepsy syndrome	0.0107	0.021	CbGbCtD
Etravirine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0106	0.0208	CbGbCtD
Etravirine—CYP2C19—Diazepam—epilepsy syndrome	0.0105	0.0205	CbGbCtD
Etravirine—CYP2C9—Phenytoin—epilepsy syndrome	0.0103	0.0202	CbGbCtD
Etravirine—CYP2C19—Zonisamide—epilepsy syndrome	0.0102	0.02	CbGbCtD
Etravirine—ABCB1—Phenytoin—epilepsy syndrome	0.01	0.0196	CbGbCtD
Etravirine—CYP3A4—Trimethadione—epilepsy syndrome	0.0099	0.0194	CbGbCtD
Etravirine—CYP3A4—Felbamate—epilepsy syndrome	0.0099	0.0194	CbGbCtD
Etravirine—CYP2C9—Propofol—epilepsy syndrome	0.00962	0.0188	CbGbCtD
Etravirine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00931	0.0182	CbGbCtD
Etravirine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00919	0.018	CbGbCtD
Etravirine—ABCB1—Phenobarbital—epilepsy syndrome	0.00892	0.0174	CbGbCtD
Etravirine—ABCB1—Midazolam—epilepsy syndrome	0.0088	0.0172	CbGbCtD
Etravirine—CYP2C9—Diazepam—epilepsy syndrome	0.00872	0.017	CbGbCtD
Etravirine—ABCB1—Diazepam—epilepsy syndrome	0.00846	0.0165	CbGbCtD
Etravirine—CYP3A4—Clonazepam—epilepsy syndrome	0.00842	0.0165	CbGbCtD
Etravirine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00826	0.0162	CbGbCtD
Etravirine—CYP3A4—Clobazam—epilepsy syndrome	0.00807	0.0158	CbGbCtD
Etravirine—CYP2C19—Topiramate—epilepsy syndrome	0.00746	0.0146	CbGbCtD
Etravirine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00687	0.0134	CbGbCtD
Etravirine—CYP3A4—Rufinamide—epilepsy syndrome	0.00686	0.0134	CbGbCtD
Etravirine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00669	0.0131	CbGbCtD
Etravirine—CYP3A4—Primidone—epilepsy syndrome	0.00624	0.0122	CbGbCtD
Etravirine—CYP3A4—Phenytoin—epilepsy syndrome	0.006	0.0117	CbGbCtD
Etravirine—CYP3A4—Propofol—epilepsy syndrome	0.00559	0.0109	CbGbCtD
Etravirine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00535	0.0105	CbGbCtD
Etravirine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00535	0.0105	CbGbCtD
Etravirine—CYP3A4—Midazolam—epilepsy syndrome	0.00527	0.0103	CbGbCtD
Etravirine—CYP3A4—Diazepam—epilepsy syndrome	0.00507	0.00991	CbGbCtD
Etravirine—CYP3A4—Zonisamide—epilepsy syndrome	0.00495	0.00967	CbGbCtD
Etravirine—CYP3A4—Valproic Acid—epilepsy syndrome	0.004	0.00781	CbGbCtD
Etravirine—CYP3A4—Topiramate—epilepsy syndrome	0.00361	0.00705	CbGbCtD
Etravirine—Rilpivirine—ABCG2—epilepsy syndrome	0.00117	0.454	CrCbGaD
Etravirine—Rilpivirine—CYP2C19—epilepsy syndrome	0.000922	0.357	CrCbGaD
Etravirine—Rilpivirine—ABCB1—epilepsy syndrome	0.000488	0.189	CrCbGaD
Etravirine—Flatulence—Gabapentin—epilepsy syndrome	6.82e-05	0.0004	CcSEcCtD
Etravirine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.81e-05	0.0004	CcSEcCtD
Etravirine—Malaise—Pregabalin—epilepsy syndrome	6.81e-05	0.0004	CcSEcCtD
Etravirine—Nausea—Propofol—epilepsy syndrome	6.81e-05	0.000399	CcSEcCtD
Etravirine—Tension—Gabapentin—epilepsy syndrome	6.79e-05	0.000399	CcSEcCtD
Etravirine—Vomiting—Fosphenytoin—epilepsy syndrome	6.79e-05	0.000399	CcSEcCtD
Etravirine—Diarrhoea—Felbamate—epilepsy syndrome	6.79e-05	0.000398	CcSEcCtD
Etravirine—Vertigo—Pregabalin—epilepsy syndrome	6.78e-05	0.000398	CcSEcCtD
Etravirine—Abdominal pain—Lamotrigine—epilepsy syndrome	6.78e-05	0.000398	CcSEcCtD
Etravirine—Body temperature increased—Lamotrigine—epilepsy syndrome	6.78e-05	0.000398	CcSEcCtD
Etravirine—Dizziness—Diazepam—epilepsy syndrome	6.78e-05	0.000398	CcSEcCtD
Etravirine—Infection—Valproic Acid—epilepsy syndrome	6.77e-05	0.000397	CcSEcCtD
Etravirine—Syncope—Pregabalin—epilepsy syndrome	6.77e-05	0.000397	CcSEcCtD
Etravirine—Rash—Fosphenytoin—epilepsy syndrome	6.74e-05	0.000395	CcSEcCtD
Etravirine—Dermatitis—Fosphenytoin—epilepsy syndrome	6.73e-05	0.000395	CcSEcCtD
Etravirine—Nervousness—Gabapentin—epilepsy syndrome	6.72e-05	0.000395	CcSEcCtD
Etravirine—Asthenia—Clonazepam—epilepsy syndrome	6.72e-05	0.000394	CcSEcCtD
Etravirine—Headache—Fosphenytoin—epilepsy syndrome	6.69e-05	0.000393	CcSEcCtD
Etravirine—Hepatitis—Topiramate—epilepsy syndrome	6.69e-05	0.000393	CcSEcCtD
Etravirine—Nervous system disorder—Valproic Acid—epilepsy syndrome	6.68e-05	0.000392	CcSEcCtD
Etravirine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.67e-05	0.000392	CcSEcCtD
Etravirine—Asthenia—Phenytoin—epilepsy syndrome	6.67e-05	0.000391	CcSEcCtD
Etravirine—Nausea—Midazolam—epilepsy syndrome	6.66e-05	0.000391	CcSEcCtD
Etravirine—Hypoaesthesia—Topiramate—epilepsy syndrome	6.66e-05	0.000391	CcSEcCtD
Etravirine—Diarrhoea—Zonisamide—epilepsy syndrome	6.65e-05	0.00039	CcSEcCtD
Etravirine—Loss of consciousness—Pregabalin—epilepsy syndrome	6.64e-05	0.000389	CcSEcCtD
Etravirine—Asthenia—Oxcarbazepine—epilepsy syndrome	6.64e-05	0.000389	CcSEcCtD
Etravirine—Vomiting—Vigabatrin—epilepsy syndrome	6.62e-05	0.000389	CcSEcCtD
Etravirine—Skin disorder—Valproic Acid—epilepsy syndrome	6.62e-05	0.000389	CcSEcCtD
Etravirine—Urinary tract disorder—Topiramate—epilepsy syndrome	6.61e-05	0.000388	CcSEcCtD
Etravirine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.59e-05	0.000387	CcSEcCtD
Etravirine—Connective tissue disorder—Topiramate—epilepsy syndrome	6.58e-05	0.000386	CcSEcCtD
Etravirine—Nausea—Levetiracetam—epilepsy syndrome	6.57e-05	0.000386	CcSEcCtD
Etravirine—Rash—Vigabatrin—epilepsy syndrome	6.57e-05	0.000385	CcSEcCtD
Etravirine—Dizziness—Felbamate—epilepsy syndrome	6.56e-05	0.000385	CcSEcCtD
Etravirine—Dermatitis—Vigabatrin—epilepsy syndrome	6.56e-05	0.000385	CcSEcCtD
Etravirine—Urethral disorder—Topiramate—epilepsy syndrome	6.56e-05	0.000385	CcSEcCtD
Etravirine—Convulsion—Pregabalin—epilepsy syndrome	6.54e-05	0.000384	CcSEcCtD
Etravirine—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.54e-05	0.000384	CcSEcCtD
Etravirine—Vision blurred—Gabapentin—epilepsy syndrome	6.52e-05	0.000383	CcSEcCtD
Etravirine—Headache—Vigabatrin—epilepsy syndrome	6.52e-05	0.000383	CcSEcCtD
Etravirine—Hypertension—Pregabalin—epilepsy syndrome	6.52e-05	0.000383	CcSEcCtD
Etravirine—Vomiting—Diazepam—epilepsy syndrome	6.52e-05	0.000383	CcSEcCtD
Etravirine—Anorexia—Valproic Acid—epilepsy syndrome	6.5e-05	0.000381	CcSEcCtD
Etravirine—Tremor—Gabapentin—epilepsy syndrome	6.49e-05	0.000381	CcSEcCtD
Etravirine—Rash—Diazepam—epilepsy syndrome	6.46e-05	0.000379	CcSEcCtD
Etravirine—Dermatitis—Diazepam—epilepsy syndrome	6.46e-05	0.000379	CcSEcCtD
Etravirine—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.42e-05	0.000377	CcSEcCtD
Etravirine—Dizziness—Zonisamide—epilepsy syndrome	6.42e-05	0.000377	CcSEcCtD
Etravirine—Headache—Diazepam—epilepsy syndrome	6.42e-05	0.000377	CcSEcCtD
Etravirine—Anxiety—Pregabalin—epilepsy syndrome	6.41e-05	0.000376	CcSEcCtD
Etravirine—Diarrhoea—Clonazepam—epilepsy syndrome	6.4e-05	0.000376	CcSEcCtD
Etravirine—Anaemia—Gabapentin—epilepsy syndrome	6.4e-05	0.000376	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.38e-05	0.000375	CcSEcCtD
Etravirine—Asthenia—Carbamazepine—epilepsy syndrome	6.37e-05	0.000374	CcSEcCtD
Etravirine—Diarrhoea—Phenytoin—epilepsy syndrome	6.36e-05	0.000373	CcSEcCtD
Etravirine—Discomfort—Pregabalin—epilepsy syndrome	6.35e-05	0.000373	CcSEcCtD
Etravirine—Nausea—Fosphenytoin—epilepsy syndrome	6.35e-05	0.000372	CcSEcCtD
Etravirine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.33e-05	0.000371	CcSEcCtD
Etravirine—Erythema multiforme—Topiramate—epilepsy syndrome	6.33e-05	0.000371	CcSEcCtD
Etravirine—Angioedema—Gabapentin—epilepsy syndrome	6.33e-05	0.000371	CcSEcCtD
Etravirine—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.32e-05	0.000371	CcSEcCtD
Etravirine—Vomiting—Felbamate—epilepsy syndrome	6.31e-05	0.00037	CcSEcCtD
Etravirine—Dry mouth—Pregabalin—epilepsy syndrome	6.29e-05	0.000369	CcSEcCtD
Etravirine—Rash—Felbamate—epilepsy syndrome	6.26e-05	0.000367	CcSEcCtD
Etravirine—Eye disorder—Topiramate—epilepsy syndrome	6.25e-05	0.000367	CcSEcCtD
Etravirine—Dermatitis—Felbamate—epilepsy syndrome	6.25e-05	0.000367	CcSEcCtD
Etravirine—Malaise—Gabapentin—epilepsy syndrome	6.24e-05	0.000366	CcSEcCtD
Etravirine—Vertigo—Gabapentin—epilepsy syndrome	6.22e-05	0.000365	CcSEcCtD
Etravirine—Headache—Felbamate—epilepsy syndrome	6.22e-05	0.000365	CcSEcCtD
Etravirine—Confusional state—Pregabalin—epilepsy syndrome	6.21e-05	0.000365	CcSEcCtD
Etravirine—Cardiac disorder—Topiramate—epilepsy syndrome	6.21e-05	0.000364	CcSEcCtD
Etravirine—Syncope—Gabapentin—epilepsy syndrome	6.21e-05	0.000364	CcSEcCtD
Etravirine—Dizziness—Clonazepam—epilepsy syndrome	6.19e-05	0.000363	CcSEcCtD
Etravirine—Nausea—Vigabatrin—epilepsy syndrome	6.19e-05	0.000363	CcSEcCtD
Etravirine—Vomiting—Zonisamide—epilepsy syndrome	6.18e-05	0.000362	CcSEcCtD
Etravirine—Insomnia—Valproic Acid—epilepsy syndrome	6.16e-05	0.000362	CcSEcCtD
Etravirine—Asthenia—Lamotrigine—epilepsy syndrome	6.15e-05	0.000361	CcSEcCtD
Etravirine—Dizziness—Phenytoin—epilepsy syndrome	6.15e-05	0.000361	CcSEcCtD
Etravirine—Rash—Zonisamide—epilepsy syndrome	6.12e-05	0.000359	CcSEcCtD
Etravirine—Infection—Pregabalin—epilepsy syndrome	6.12e-05	0.000359	CcSEcCtD
Etravirine—Paraesthesia—Valproic Acid—epilepsy syndrome	6.12e-05	0.000359	CcSEcCtD
Etravirine—Dermatitis—Zonisamide—epilepsy syndrome	6.12e-05	0.000359	CcSEcCtD
Etravirine—Dizziness—Oxcarbazepine—epilepsy syndrome	6.12e-05	0.000359	CcSEcCtD
Etravirine—Nausea—Diazepam—epilepsy syndrome	6.09e-05	0.000357	CcSEcCtD
Etravirine—Loss of consciousness—Gabapentin—epilepsy syndrome	6.09e-05	0.000357	CcSEcCtD
Etravirine—Headache—Zonisamide—epilepsy syndrome	6.08e-05	0.000357	CcSEcCtD
Etravirine—Diarrhoea—Carbamazepine—epilepsy syndrome	6.07e-05	0.000356	CcSEcCtD
Etravirine—Angiopathy—Topiramate—epilepsy syndrome	6.07e-05	0.000356	CcSEcCtD
Etravirine—Shock—Pregabalin—epilepsy syndrome	6.06e-05	0.000356	CcSEcCtD
Etravirine—Somnolence—Valproic Acid—epilepsy syndrome	6.06e-05	0.000356	CcSEcCtD
Etravirine—Immune system disorder—Topiramate—epilepsy syndrome	6.04e-05	0.000355	CcSEcCtD
Etravirine—Nervous system disorder—Pregabalin—epilepsy syndrome	6.04e-05	0.000355	CcSEcCtD
Etravirine—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.03e-05	0.000354	CcSEcCtD
Etravirine—Mediastinal disorder—Topiramate—epilepsy syndrome	6.03e-05	0.000354	CcSEcCtD
Etravirine—Convulsion—Gabapentin—epilepsy syndrome	6e-05	0.000352	CcSEcCtD
Etravirine—Skin disorder—Pregabalin—epilepsy syndrome	5.99e-05	0.000351	CcSEcCtD
Etravirine—Hypertension—Gabapentin—epilepsy syndrome	5.98e-05	0.000351	CcSEcCtD
Etravirine—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.96e-05	0.00035	CcSEcCtD
Etravirine—Vomiting—Clonazepam—epilepsy syndrome	5.95e-05	0.000349	CcSEcCtD
Etravirine—Decreased appetite—Valproic Acid—epilepsy syndrome	5.93e-05	0.000348	CcSEcCtD
Etravirine—Vomiting—Phenytoin—epilepsy syndrome	5.91e-05	0.000347	CcSEcCtD
Etravirine—Rash—Clonazepam—epilepsy syndrome	5.9e-05	0.000346	CcSEcCtD
Etravirine—Dermatitis—Clonazepam—epilepsy syndrome	5.9e-05	0.000346	CcSEcCtD
Etravirine—Nausea—Felbamate—epilepsy syndrome	5.89e-05	0.000346	CcSEcCtD
Etravirine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.88e-05	0.000345	CcSEcCtD
Etravirine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.88e-05	0.000345	CcSEcCtD
Etravirine—Fatigue—Valproic Acid—epilepsy syndrome	5.88e-05	0.000345	CcSEcCtD
Etravirine—Anxiety—Gabapentin—epilepsy syndrome	5.87e-05	0.000345	CcSEcCtD
Etravirine—Anorexia—Pregabalin—epilepsy syndrome	5.87e-05	0.000345	CcSEcCtD
Etravirine—Dizziness—Carbamazepine—epilepsy syndrome	5.87e-05	0.000344	CcSEcCtD
Etravirine—Diarrhoea—Lamotrigine—epilepsy syndrome	5.87e-05	0.000344	CcSEcCtD
Etravirine—Headache—Clonazepam—epilepsy syndrome	5.86e-05	0.000344	CcSEcCtD
Etravirine—Rash—Phenytoin—epilepsy syndrome	5.86e-05	0.000344	CcSEcCtD
Etravirine—Mental disorder—Topiramate—epilepsy syndrome	5.86e-05	0.000344	CcSEcCtD
Etravirine—Dermatitis—Phenytoin—epilepsy syndrome	5.86e-05	0.000344	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.85e-05	0.000344	CcSEcCtD
Etravirine—Rash—Oxcarbazepine—epilepsy syndrome	5.83e-05	0.000342	CcSEcCtD
Etravirine—Pain—Valproic Acid—epilepsy syndrome	5.83e-05	0.000342	CcSEcCtD
Etravirine—Constipation—Valproic Acid—epilepsy syndrome	5.83e-05	0.000342	CcSEcCtD
Etravirine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.83e-05	0.000342	CcSEcCtD
Etravirine—Headache—Phenytoin—epilepsy syndrome	5.82e-05	0.000342	CcSEcCtD
Etravirine—Malnutrition—Topiramate—epilepsy syndrome	5.82e-05	0.000342	CcSEcCtD
Etravirine—Discomfort—Gabapentin—epilepsy syndrome	5.82e-05	0.000342	CcSEcCtD
Etravirine—Headache—Oxcarbazepine—epilepsy syndrome	5.79e-05	0.00034	CcSEcCtD
Etravirine—Nausea—Zonisamide—epilepsy syndrome	5.77e-05	0.000339	CcSEcCtD
Etravirine—Dry mouth—Gabapentin—epilepsy syndrome	5.76e-05	0.000338	CcSEcCtD
Etravirine—Flatulence—Topiramate—epilepsy syndrome	5.74e-05	0.000337	CcSEcCtD
Etravirine—Tension—Topiramate—epilepsy syndrome	5.72e-05	0.000335	CcSEcCtD
Etravirine—Confusional state—Gabapentin—epilepsy syndrome	5.7e-05	0.000334	CcSEcCtD
Etravirine—Dizziness—Lamotrigine—epilepsy syndrome	5.67e-05	0.000333	CcSEcCtD
Etravirine—Nervousness—Topiramate—epilepsy syndrome	5.66e-05	0.000332	CcSEcCtD
Etravirine—Vomiting—Carbamazepine—epilepsy syndrome	5.64e-05	0.000331	CcSEcCtD
Etravirine—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.62e-05	0.00033	CcSEcCtD
Etravirine—Infection—Gabapentin—epilepsy syndrome	5.61e-05	0.000329	CcSEcCtD
Etravirine—Rash—Carbamazepine—epilepsy syndrome	5.6e-05	0.000328	CcSEcCtD
Etravirine—Dermatitis—Carbamazepine—epilepsy syndrome	5.59e-05	0.000328	CcSEcCtD
Etravirine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.57e-05	0.000327	CcSEcCtD
Etravirine—Insomnia—Pregabalin—epilepsy syndrome	5.57e-05	0.000327	CcSEcCtD
Etravirine—Nausea—Clonazepam—epilepsy syndrome	5.56e-05	0.000326	CcSEcCtD
Etravirine—Headache—Carbamazepine—epilepsy syndrome	5.56e-05	0.000326	CcSEcCtD
Etravirine—Shock—Gabapentin—epilepsy syndrome	5.56e-05	0.000326	CcSEcCtD
Etravirine—Nervous system disorder—Gabapentin—epilepsy syndrome	5.54e-05	0.000325	CcSEcCtD
Etravirine—Paraesthesia—Pregabalin—epilepsy syndrome	5.53e-05	0.000325	CcSEcCtD
Etravirine—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.53e-05	0.000325	CcSEcCtD
Etravirine—Nausea—Phenytoin—epilepsy syndrome	5.52e-05	0.000324	CcSEcCtD
Etravirine—Nausea—Oxcarbazepine—epilepsy syndrome	5.49e-05	0.000322	CcSEcCtD
Etravirine—Vision blurred—Topiramate—epilepsy syndrome	5.49e-05	0.000322	CcSEcCtD
Etravirine—Skin disorder—Gabapentin—epilepsy syndrome	5.49e-05	0.000322	CcSEcCtD
Etravirine—Somnolence—Pregabalin—epilepsy syndrome	5.48e-05	0.000321	CcSEcCtD
Etravirine—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.46e-05	0.000321	CcSEcCtD
Etravirine—Tremor—Topiramate—epilepsy syndrome	5.46e-05	0.00032	CcSEcCtD
Etravirine—Vomiting—Lamotrigine—epilepsy syndrome	5.45e-05	0.00032	CcSEcCtD
Etravirine—Rash—Lamotrigine—epilepsy syndrome	5.41e-05	0.000317	CcSEcCtD
Etravirine—Ill-defined disorder—Topiramate—epilepsy syndrome	5.4e-05	0.000317	CcSEcCtD
Etravirine—Dermatitis—Lamotrigine—epilepsy syndrome	5.4e-05	0.000317	CcSEcCtD
Etravirine—Abdominal pain—Valproic Acid—epilepsy syndrome	5.39e-05	0.000316	CcSEcCtD
Etravirine—Body temperature increased—Valproic Acid—epilepsy syndrome	5.39e-05	0.000316	CcSEcCtD
Etravirine—Anorexia—Gabapentin—epilepsy syndrome	5.39e-05	0.000316	CcSEcCtD
Etravirine—Anaemia—Topiramate—epilepsy syndrome	5.38e-05	0.000316	CcSEcCtD
Etravirine—Headache—Lamotrigine—epilepsy syndrome	5.37e-05	0.000315	CcSEcCtD
Etravirine—Decreased appetite—Pregabalin—epilepsy syndrome	5.36e-05	0.000314	CcSEcCtD
Etravirine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.32e-05	0.000312	CcSEcCtD
Etravirine—Fatigue—Pregabalin—epilepsy syndrome	5.31e-05	0.000312	CcSEcCtD
Etravirine—Nausea—Carbamazepine—epilepsy syndrome	5.27e-05	0.000309	CcSEcCtD
Etravirine—Pain—Pregabalin—epilepsy syndrome	5.27e-05	0.000309	CcSEcCtD
Etravirine—Constipation—Pregabalin—epilepsy syndrome	5.27e-05	0.000309	CcSEcCtD
Etravirine—Malaise—Topiramate—epilepsy syndrome	5.25e-05	0.000308	CcSEcCtD
Etravirine—Vertigo—Topiramate—epilepsy syndrome	5.23e-05	0.000307	CcSEcCtD
Etravirine—Syncope—Topiramate—epilepsy syndrome	5.22e-05	0.000307	CcSEcCtD
Etravirine—Loss of consciousness—Topiramate—epilepsy syndrome	5.12e-05	0.0003	CcSEcCtD
Etravirine—Insomnia—Gabapentin—epilepsy syndrome	5.11e-05	0.0003	CcSEcCtD
Etravirine—Nausea—Lamotrigine—epilepsy syndrome	5.09e-05	0.000299	CcSEcCtD
Etravirine—Feeling abnormal—Pregabalin—epilepsy syndrome	5.08e-05	0.000298	CcSEcCtD
Etravirine—Paraesthesia—Gabapentin—epilepsy syndrome	5.07e-05	0.000298	CcSEcCtD
Etravirine—Convulsion—Topiramate—epilepsy syndrome	5.05e-05	0.000296	CcSEcCtD
Etravirine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.04e-05	0.000296	CcSEcCtD
Etravirine—Hypertension—Topiramate—epilepsy syndrome	5.03e-05	0.000295	CcSEcCtD
Etravirine—Somnolence—Gabapentin—epilepsy syndrome	5.02e-05	0.000295	CcSEcCtD
Etravirine—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.02e-05	0.000295	CcSEcCtD
Etravirine—Anxiety—Topiramate—epilepsy syndrome	4.94e-05	0.00029	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.92e-05	0.000289	CcSEcCtD
Etravirine—Decreased appetite—Gabapentin—epilepsy syndrome	4.91e-05	0.000288	CcSEcCtD
Etravirine—Discomfort—Topiramate—epilepsy syndrome	4.9e-05	0.000288	CcSEcCtD
Etravirine—Asthenia—Valproic Acid—epilepsy syndrome	4.89e-05	0.000287	CcSEcCtD
Etravirine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.88e-05	0.000286	CcSEcCtD
Etravirine—Fatigue—Gabapentin—epilepsy syndrome	4.87e-05	0.000286	CcSEcCtD
Etravirine—Body temperature increased—Pregabalin—epilepsy syndrome	4.87e-05	0.000286	CcSEcCtD
Etravirine—Abdominal pain—Pregabalin—epilepsy syndrome	4.87e-05	0.000286	CcSEcCtD
Etravirine—Dry mouth—Topiramate—epilepsy syndrome	4.85e-05	0.000285	CcSEcCtD
Etravirine—Pain—Gabapentin—epilepsy syndrome	4.83e-05	0.000284	CcSEcCtD
Etravirine—Constipation—Gabapentin—epilepsy syndrome	4.83e-05	0.000284	CcSEcCtD
Etravirine—Confusional state—Topiramate—epilepsy syndrome	4.79e-05	0.000281	CcSEcCtD
Etravirine—Infection—Topiramate—epilepsy syndrome	4.72e-05	0.000277	CcSEcCtD
Etravirine—Shock—Topiramate—epilepsy syndrome	4.68e-05	0.000274	CcSEcCtD
Etravirine—Diarrhoea—Valproic Acid—epilepsy syndrome	4.66e-05	0.000274	CcSEcCtD
Etravirine—Nervous system disorder—Topiramate—epilepsy syndrome	4.66e-05	0.000274	CcSEcCtD
Etravirine—Feeling abnormal—Gabapentin—epilepsy syndrome	4.66e-05	0.000273	CcSEcCtD
Etravirine—Thrombocytopenia—Topiramate—epilepsy syndrome	4.65e-05	0.000273	CcSEcCtD
Etravirine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.62e-05	0.000271	CcSEcCtD
Etravirine—Skin disorder—Topiramate—epilepsy syndrome	4.62e-05	0.000271	CcSEcCtD
Etravirine—Hyperhidrosis—Topiramate—epilepsy syndrome	4.6e-05	0.00027	CcSEcCtD
Etravirine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.54e-05	0.000266	CcSEcCtD
Etravirine—Anorexia—Topiramate—epilepsy syndrome	4.53e-05	0.000266	CcSEcCtD
Etravirine—Dizziness—Valproic Acid—epilepsy syndrome	4.51e-05	0.000265	CcSEcCtD
Etravirine—Abdominal pain—Gabapentin—epilepsy syndrome	4.47e-05	0.000262	CcSEcCtD
Etravirine—Body temperature increased—Gabapentin—epilepsy syndrome	4.47e-05	0.000262	CcSEcCtD
Etravirine—Asthenia—Pregabalin—epilepsy syndrome	4.42e-05	0.000259	CcSEcCtD
Etravirine—Vomiting—Valproic Acid—epilepsy syndrome	4.33e-05	0.000254	CcSEcCtD
Etravirine—Insomnia—Topiramate—epilepsy syndrome	4.3e-05	0.000252	CcSEcCtD
Etravirine—Rash—Valproic Acid—epilepsy syndrome	4.3e-05	0.000252	CcSEcCtD
Etravirine—Dermatitis—Valproic Acid—epilepsy syndrome	4.29e-05	0.000252	CcSEcCtD
Etravirine—Headache—Valproic Acid—epilepsy syndrome	4.27e-05	0.000251	CcSEcCtD
Etravirine—Paraesthesia—Topiramate—epilepsy syndrome	4.27e-05	0.000251	CcSEcCtD
Etravirine—Somnolence—Topiramate—epilepsy syndrome	4.23e-05	0.000248	CcSEcCtD
Etravirine—Diarrhoea—Pregabalin—epilepsy syndrome	4.22e-05	0.000247	CcSEcCtD
Etravirine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.16e-05	0.000244	CcSEcCtD
Etravirine—Decreased appetite—Topiramate—epilepsy syndrome	4.13e-05	0.000243	CcSEcCtD
Etravirine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.1e-05	0.000241	CcSEcCtD
Etravirine—Fatigue—Topiramate—epilepsy syndrome	4.1e-05	0.000241	CcSEcCtD
Etravirine—Dizziness—Pregabalin—epilepsy syndrome	4.07e-05	0.000239	CcSEcCtD
Etravirine—Constipation—Topiramate—epilepsy syndrome	4.07e-05	0.000239	CcSEcCtD
Etravirine—Pain—Topiramate—epilepsy syndrome	4.07e-05	0.000239	CcSEcCtD
Etravirine—Asthenia—Gabapentin—epilepsy syndrome	4.05e-05	0.000238	CcSEcCtD
Etravirine—Nausea—Valproic Acid—epilepsy syndrome	4.05e-05	0.000238	CcSEcCtD
Etravirine—Vomiting—Pregabalin—epilepsy syndrome	3.92e-05	0.00023	CcSEcCtD
Etravirine—Feeling abnormal—Topiramate—epilepsy syndrome	3.92e-05	0.00023	CcSEcCtD
Etravirine—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.89e-05	0.000228	CcSEcCtD
Etravirine—Rash—Pregabalin—epilepsy syndrome	3.89e-05	0.000228	CcSEcCtD
Etravirine—Dermatitis—Pregabalin—epilepsy syndrome	3.88e-05	0.000228	CcSEcCtD
Etravirine—Diarrhoea—Gabapentin—epilepsy syndrome	3.87e-05	0.000227	CcSEcCtD
Etravirine—Headache—Pregabalin—epilepsy syndrome	3.86e-05	0.000227	CcSEcCtD
Etravirine—Abdominal pain—Topiramate—epilepsy syndrome	3.76e-05	0.000221	CcSEcCtD
Etravirine—Body temperature increased—Topiramate—epilepsy syndrome	3.76e-05	0.000221	CcSEcCtD
Etravirine—Dizziness—Gabapentin—epilepsy syndrome	3.74e-05	0.000219	CcSEcCtD
Etravirine—Nausea—Pregabalin—epilepsy syndrome	3.66e-05	0.000215	CcSEcCtD
Etravirine—Vomiting—Gabapentin—epilepsy syndrome	3.59e-05	0.000211	CcSEcCtD
Etravirine—Rash—Gabapentin—epilepsy syndrome	3.56e-05	0.000209	CcSEcCtD
Etravirine—Dermatitis—Gabapentin—epilepsy syndrome	3.56e-05	0.000209	CcSEcCtD
Etravirine—Headache—Gabapentin—epilepsy syndrome	3.54e-05	0.000208	CcSEcCtD
Etravirine—Hypersensitivity—Topiramate—epilepsy syndrome	3.5e-05	0.000206	CcSEcCtD
Etravirine—Asthenia—Topiramate—epilepsy syndrome	3.41e-05	0.0002	CcSEcCtD
Etravirine—Nausea—Gabapentin—epilepsy syndrome	3.36e-05	0.000197	CcSEcCtD
Etravirine—Diarrhoea—Topiramate—epilepsy syndrome	3.25e-05	0.000191	CcSEcCtD
Etravirine—Dizziness—Topiramate—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Etravirine—Vomiting—Topiramate—epilepsy syndrome	3.02e-05	0.000177	CcSEcCtD
Etravirine—Rash—Topiramate—epilepsy syndrome	3e-05	0.000176	CcSEcCtD
Etravirine—Dermatitis—Topiramate—epilepsy syndrome	2.99e-05	0.000176	CcSEcCtD
Etravirine—Headache—Topiramate—epilepsy syndrome	2.98e-05	0.000175	CcSEcCtD
Etravirine—Nausea—Topiramate—epilepsy syndrome	2.82e-05	0.000166	CcSEcCtD
Etravirine—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.58e-05	0.00057	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.58e-05	0.00057	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.58e-05	0.00057	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS2—epilepsy syndrome	1.55e-05	0.00056	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.53e-05	0.000553	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.53e-05	0.000553	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.51e-05	0.000544	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—QDPR—epilepsy syndrome	1.5e-05	0.000543	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA4—epilepsy syndrome	1.5e-05	0.000543	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	1.5e-05	0.000541	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.47e-05	0.000532	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.47e-05	0.000532	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.47e-05	0.000532	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.47e-05	0.000532	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.47e-05	0.00053	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.47e-05	0.00053	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA4—epilepsy syndrome	1.47e-05	0.00053	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.46e-05	0.00053	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.41e-05	0.00051	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.4e-05	0.000507	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—COX3—epilepsy syndrome	1.38e-05	0.000498	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.37e-05	0.000495	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.37e-05	0.000495	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.36e-05	0.000493	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.36e-05	0.000492	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.34e-05	0.000484	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.34e-05	0.000484	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.34e-05	0.000484	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.34e-05	0.000484	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.34e-05	0.000484	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.31e-05	0.000475	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.31e-05	0.000472	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.31e-05	0.000472	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.31e-05	0.000472	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.31e-05	0.000472	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.31e-05	0.000472	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.3e-05	0.00047	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.29e-05	0.000465	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.26e-05	0.000456	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.25e-05	0.00045	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.22e-05	0.000443	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.22e-05	0.000443	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.22e-05	0.000443	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.22e-05	0.000441	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.22e-05	0.000441	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.22e-05	0.000441	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.22e-05	0.000441	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.22e-05	0.000441	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.21e-05	0.000439	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.19e-05	0.000432	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.19e-05	0.000432	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.19e-05	0.000432	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.19e-05	0.000431	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.19e-05	0.00043	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.18e-05	0.000429	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	1.18e-05	0.000426	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.15e-05	0.000416	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	1.14e-05	0.000411	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GBE1—epilepsy syndrome	1.14e-05	0.000411	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.13e-05	0.000408	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.12e-05	0.000404	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.12e-05	0.000404	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.12e-05	0.000404	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.11e-05	0.000402	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.11e-05	0.000402	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.11e-05	0.000402	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.07e-05	0.000388	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.07e-05	0.000387	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	1.07e-05	0.000387	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.06e-05	0.000384	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.06e-05	0.000384	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.06e-05	0.000384	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.06e-05	0.000384	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.06e-05	0.000384	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.06e-05	0.000384	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.04e-05	0.000378	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	1.04e-05	0.000376	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.04e-05	0.000375	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.04e-05	0.000375	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.03e-05	0.000373	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.02e-05	0.000367	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NT5E—epilepsy syndrome	1.01e-05	0.000367	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALAD—epilepsy syndrome	1.01e-05	0.000367	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.01e-05	0.000367	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	9.94e-06	0.00036	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NT5E—epilepsy syndrome	9.9e-06	0.000358	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALAD—epilepsy syndrome	9.9e-06	0.000358	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	9.84e-06	0.000356	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	9.75e-06	0.000353	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.71e-06	0.000351	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.71e-06	0.000351	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.71e-06	0.000351	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.71e-06	0.000351	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	9.67e-06	0.00035	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	9.67e-06	0.00035	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	9.66e-06	0.000349	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	9.49e-06	0.000343	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	9.47e-06	0.000342	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	9.44e-06	0.000341	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	9.44e-06	0.000341	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADSL—epilepsy syndrome	9.27e-06	0.000335	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NT5E—epilepsy syndrome	9.25e-06	0.000334	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALAD—epilepsy syndrome	9.25e-06	0.000334	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	9.24e-06	0.000334	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GLUL—epilepsy syndrome	9.09e-06	0.000329	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADSL—epilepsy syndrome	9.05e-06	0.000327	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA4—epilepsy syndrome	9.03e-06	0.000326	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	9.03e-06	0.000326	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	9e-06	0.000325	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	8.93e-06	0.000323	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GLUL—epilepsy syndrome	8.88e-06	0.000321	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	8.82e-06	0.000319	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	8.82e-06	0.000319	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	8.71e-06	0.000315	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	8.66e-06	0.000313	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	8.63e-06	0.000312	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.49e-06	0.000307	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADSL—epilepsy syndrome	8.46e-06	0.000306	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	8.44e-06	0.000305	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	8.35e-06	0.000302	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GLUL—epilepsy syndrome	8.29e-06	0.0003	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	8.15e-06	0.000295	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	8.14e-06	0.000294	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AQP1—epilepsy syndrome	8.11e-06	0.000293	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	8.1e-06	0.000293	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	8.05e-06	0.000291	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	8.05e-06	0.000291	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	8.05e-06	0.000291	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	8.05e-06	0.000291	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	8.05e-06	0.000291	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	8.02e-06	0.00029	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AQP1—epilepsy syndrome	7.91e-06	0.000286	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.79e-06	0.000282	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—AKT1—epilepsy syndrome	7.78e-06	0.000281	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	7.61e-06	0.000275	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	7.39e-06	0.000267	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.36e-06	0.000266	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.36e-06	0.000266	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.36e-06	0.000266	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	7.33e-06	0.000265	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	7.33e-06	0.000265	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.23e-06	0.000262	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CHRM3—epilepsy syndrome	7.15e-06	0.000259	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	7.15e-06	0.000259	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.1e-06	0.000257	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	7.08e-06	0.000256	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.84e-06	0.000247	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.84e-06	0.000247	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.83e-06	0.000247	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.69e-06	0.000242	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	6.68e-06	0.000242	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	6.68e-06	0.000242	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.43e-06	0.000233	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.26e-06	0.000226	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.22e-06	0.000225	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.1e-06	0.000221	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.1e-06	0.000221	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.1e-06	0.000221	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	5.98e-06	0.000216	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	5.83e-06	0.000211	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.82e-06	0.00021	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.82e-06	0.00021	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	5.79e-06	0.000209	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.75e-06	0.000208	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.69e-06	0.000206	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	5.68e-06	0.000206	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	5.65e-06	0.000204	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.58e-06	0.000202	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.47e-06	0.000198	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.45e-06	0.000197	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.38e-06	0.000195	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.37e-06	0.000194	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.31e-06	0.000192	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.28e-06	0.000191	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.24e-06	0.000189	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.24e-06	0.000189	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	5.22e-06	0.000189	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	5.1e-06	0.000184	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.02e-06	0.000182	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	4.97e-06	0.00018	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	4.95e-06	0.000179	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.87e-06	0.000176	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.86e-06	0.000176	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.85e-06	0.000176	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.83e-06	0.000175	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.78e-06	0.000173	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.76e-06	0.000172	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	4.72e-06	0.000171	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	4.67e-06	0.000169	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TH—epilepsy syndrome	4.66e-06	0.000168	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.61e-06	0.000167	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.58e-06	0.000166	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.56e-06	0.000165	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TH—epilepsy syndrome	4.54e-06	0.000164	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.53e-06	0.000164	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.51e-06	0.000163	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.41e-06	0.000159	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.41e-06	0.000159	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.31e-06	0.000156	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.26e-06	0.000154	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TH—epilepsy syndrome	4.24e-06	0.000154	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.18e-06	0.000151	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.89e-06	0.000141	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.83e-06	0.000139	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.79e-06	0.000137	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAT—epilepsy syndrome	3.74e-06	0.000135	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.73e-06	0.000135	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.59e-06	0.00013	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.54e-06	0.000128	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.5e-06	0.000127	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.5e-06	0.000126	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.48e-06	0.000126	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.47e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.4e-06	0.000123	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.38e-06	0.000122	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.16e-06	0.000114	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.14e-06	0.000114	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.04e-06	0.00011	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.99e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.98e-06	0.000108	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.98e-06	0.000108	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AGT—epilepsy syndrome	2.97e-06	0.000107	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOE—epilepsy syndrome	2.91e-06	0.000105	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.84e-06	0.000103	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.81e-06	0.000102	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.8e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.77e-06	0.0001	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.72e-06	9.82e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.56e-06	9.26e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—POMC—epilepsy syndrome	2.5e-06	9.03e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.34e-06	8.45e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.33e-06	8.44e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.33e-06	8.44e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.31e-06	8.34e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—epilepsy syndrome	2.28e-06	8.24e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.24e-06	8.11e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.13e-06	7.69e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.08e-06	7.54e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.04e-06	7.38e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.99e-06	7.21e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.86e-06	6.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.83e-06	6.61e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.79e-06	6.48e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.54e-06	5.57e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.4e-06	5.07e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	4.44e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.03e-06	3.71e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—epilepsy syndrome	1e-06	3.62e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	9.35e-07	3.38e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.17e-07	2.23e-05	CbGpPWpGaD
